The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rabies Vaccine BP > 2.5 IU/ml, Powder and solvent for suspension for injection

2.5 international unit(s)/millilitre Suspension for injection

Sanofi PasteurPA2131/004/001

Main Information

Trade NameRabies Vaccine BP > 2.5 IU/ml, Powder and solvent for suspension for injection
Active SubstancesInactivated Rabies Virus Strain PM/WI 38 1503 3M
Strength2.5 international unit(s)/millilitre
Dosage FormSuspension for injection
Licence HolderSanofi Pasteur
Licence NumberPA2131/004/001

Group Information

ATC CodeJ07BG Rabies vaccines
J07BG01 rabies, inactivated, whole virus


Licence Issued12/12/1994
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back